Picture of Nutex Befektetesi Nyrt logo

NUTEX Nutex Befektetesi Nyrt Income Statement

0.000.00%
hu flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Nutex Befektetesi Nyrt, fiscal year end - December 31st, HUF millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.450.450.450.450.45
Cost of Revenue
Gross Profit0.450.45
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses1813.616.421.597.6
Operating Profit-17.6-13.1-16-21.1-97.1
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes27.313.3139178466
Provision for Income Taxes
Net Income After Taxes26.112.7134171423
Net Income Before Extraordinary Items
Net Income26.112.7134171423
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income26.112.7134171423
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.3650.0860.9021.162.86
Dividends per Share